Webcasts

The development of minimally invasive surgical technologies has revolutionized healthcare by making possible a growing variety of complex cardiovascular and neurological interventions that would otherwise be unthinkable. But using the body’s vascular system like a network of access routes is not without challenges—including especially the need for intravascular access catheters that can be used in interventional procedures relying on magnetic resonance imaging.

To overcome the incompatibility of traditional materials with MRI-based visualization, Zeus Industrial Products has recently identified a polymer with characteristics suitable to replace the metallic reinforcement braiding used in intravascular access catheters. The company’s research has demonstrated the utility of a thermotropic liquid crystal polymer (LCP) monofilament—a polyarylate monofilament whose properties seem likely to alter the landscape of catheter manufacturing in the not-too-distant future.

Join Medical Design Briefs for this free webcast, which will examine how the use of LCP monofilament in catheter braiding is supporting the development of advanced surgical procedures—in cardiology and beyond. Key topics covered in the program will include:

  • Minimally invasive surgery and the challenge of visualization.
  • Fluoroscopy versus magnetic resonance imaging.
  • Functional properties of liquid crystal polymer monofilament.
  • Processing characteristics and additive-driven traits of liquid crystal polymer.
  • Practical experience from the use of liquid crystal polymer monofilament as a reinforcement braid for catheters.
  • Future prospects for liquid crystal polymer in medical products.

Speakers:

Bruce Anneaux, PhD, Corporate Director, Research and Development, Zeus Industrial Products, Inc.
Emily Barnes, Senior Global Market Manager, Cardiac Rhythm Management/Electrophysiology, Zeus Industrial Products, Inc.
Zahidul Wahab, PhD, Senior Research Engineer, Zeus Industrial Products, Inc.

Click here to view webinar

The U.S. Government does not endorse any commercial product, process, or activity identified on this web site.